Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.43 | 11.40 | 4.24 | 3.97 | 3.88 | 0.03 | 0.02 | 0.02 | 0.07 | 0.06 | 0.06 | 0.05 |
| Expenses | 10.42 | 9.91 | 3.27 | 3.74 | -27.09 | 1.78 | 1.06 | 0.40 | 4.45 | 0.75 | -2.01 | 0.22 |
| Operating Profit | 2.01 | 1.49 | 0.97 | 0.23 | 30.97 | -1.75 | -1.04 | -0.38 | -4.38 | -0.69 | 2.07 | -0.17 |
| OPM % | 16.17% | 13.07% | 22.88% | 5.79% | 798.20% | -5,833.33% | -5,200.00% | -1,900.00% | -6,257.14% | -1,150.00% | 3,450.00% | -340.00% |
| Other Income | 0.26 | 0.57 | 2.08 | 0.48 | -73.97 | 0.00 | 2.03 | 0.00 | 0.10 | 0.03 | -4.17 | 0.01 |
| Interest | 0.15 | 0.09 | 0.09 | 0.09 | 0.06 | 0.07 | 0.07 | 0.08 | 0.10 | 0.08 | 0.12 | 0.06 |
| Depreciation | 0.36 | 0.36 | 0.34 | 0.32 | 0.28 | 0.28 | 0.25 | 0.23 | 0.23 | 0.22 | 0.20 | 0.20 |
| Profit before tax | 1.76 | 1.61 | 2.62 | 0.30 | -43.34 | -2.10 | 0.67 | -0.69 | -4.61 | -0.96 | -2.42 | -0.42 |
| Tax % | 28.41% | 30.43% | -227.48% | 26.67% | -0.18% | 0.00% | -47.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 1.26 | 1.12 | 8.58 | 0.23 | -43.27 | -2.10 | 0.99 | -0.70 | -4.61 | -0.96 | -2.42 | -0.42 |
| EPS in Rs | 0.23 | 0.21 | 1.59 | 0.04 | -8.01 | -0.39 | 0.18 | -0.13 | -0.85 | -0.18 | -0.45 | -0.08 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.21 | 0.24 |
| Expenses | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -20.80 | 3.22 | 3.41 |
| Operating Profit | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 28.70 | -3.01 | -3.17 |
| OPM % | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 363.29% | -1,433.33% | -1,320.83% |
| Other Income | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | -4.39 | -4.03 |
| Interest | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.33 | 0.40 | 0.36 |
| Depreciation | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.88 | 0.85 |
| Profit before tax | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -8.68 | -8.41 |
| Tax % | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | 0.00% | |
| Net Profit | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -8.68 | -8.41 |
| EPS in Rs | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -1.61 | -1.56 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -15% | -64% | -83% | -94% | ||
| Compounded Profit Growth | % | % | % | -114% | ||
| Stock Price CAGR | -16% | -38% | -38% | -63% | ||
| Return on Equity | 33% | 35% | 39% | -35% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 54.01 | 54.01 | 54.01 | 54.01 |
| Reserves | -28.18 | -28.16 | -28.01 | -27.15 | -27.13 | -27.09 | -23.03 | -17.86 | -8.21 | 4.36 | -40.56 | -44.56 |
| Borrowings | 0.56 | 0.56 | 0.10 | 0.28 | 5.60 | 9.53 | 5.50 | 4.26 | 4.32 | 3.65 | 3.39 | 5.17 |
| Other Liabilities | 0.04 | 0.08 | 1.31 | 4.66 | 3.22 | 2.59 | 5.81 | 21.34 | 24.46 | 7.94 | 29.25 | 28.46 |
| Total Liabilities | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.09 | 43.08 |
| Fixed Assets | 1.74 | 1.84 | 2.44 | 7.24 | 8.61 | 9.52 | 8.01 | 6.82 | 6.93 | 5.95 | 4.00 | 2.90 |
| CWIP | 0.00 | 0.00 | 0.60 | 0.86 | 0.06 | 0.04 | 0.09 | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.78 | 2.74 | 2.46 | 1.79 | 5.12 | 7.57 | 12.28 | 32.93 | 67.56 | 63.95 | 42.09 | 40.18 |
| Total Assets | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.09 | 43.08 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.07 | 0.34 | 0.46 | 3.04 | -4.12 | -1.29 | 3.90 | 1.68 | -5.26 | -0.37 | -17.32 | -6.04 |
| Cash from Investing Activity | -1.77 | -0.48 | -1.45 | -5.45 | -1.51 | -2.32 | -0.26 | -0.25 | -1.54 | -0.41 | 0.65 | 0.00 |
| Cash from Financing Activity | 4.52 | 0.00 | 0.78 | 0.26 | 5.86 | 4.75 | -4.82 | -1.67 | 25.87 | -1.04 | -0.55 | 6.07 |
| Net Cash Flow | 2.68 | -0.14 | -0.21 | -2.14 | 0.23 | 1.14 | -1.17 | -0.23 | 19.08 | -1.83 | -17.22 | 0.03 |
| Free Cash Flow | -1.84 | -0.14 | -0.99 | -2.41 | -5.63 | -3.61 | 3.64 | 1.42 | -6.80 | -0.78 | -16.67 | -6.04 |
| CFO/OP | 41% | 162% | 192% | 241% | -280% | -56% | 67% | 41% | -39% | -74% | -60% | 201% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | 112.67 | 93.21 | 186.19 | 251.96 | 310.35 | 93.33 | 1,755.48 |
| Inventory Days | 149.08 | 29.44 | 3.74 | 6.18 | 16.46 | 138,809.50 | ||||||
| Days Payable | 976.76 | 211.94 | 382.44 | 386.99 | 112.66 | 86,286.00 | ||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | -715.01 | -89.29 | -192.52 | -128.86 | 214.15 | 93.33 | 54,278.98 |
| Working Capital Days | -2,920.00 | -160.33 | -271.72 | -311.55 | -145.85 | -16.25 | 54.71 | 99.86 | 149.42 | 254.98 | 402.42 | 9,855.00 |
| ROCE % | -3.97% | 0.67% | 4.60% | 25.48% | 7.09% | 8.04% | 46.58% | 45.78% | 23.40% | 15.44% | 77.91% | -23.20% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 17.47% |
| FIIs | 0.00% | 0.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% |
| Public | 81.38% | 81.17% | 81.38% | 81.37% | 81.37% | 81.38% | 81.38% | 81.38% | 81.37% | 81.37% | 81.38% | 82.44% |
| No. of Shareholders | 39,157 | 38,892 | 41,956 | 42,155 | 45,369 | 48,177 | 47,953 | 47,433 | 47,432 | 46,710 | 46,007 | 45,758 |
Fundamentals
Market Cap₹ 9.61 Cr.
Current Price₹ 1.78
Book Value₹ 1.75
ROCE-23.2 %
ROE-35.4 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-94%
Compounded Profit Growth (TTM)-114%
Standalone figures.
Valuation
Market capRs 10 Cr
Enterprise valueRs 14 Cr
Price to book1.01x
Price to sales39.61x
EV / sales60.07x
Earnings yield-88.46%
P/E, 3-year average3.01x
P/B, 3-year average1.20x
P/E, 5-year average8.56x
P/B, 5-year average1.80x
Profitability
Operating margin (excl. other income)-1433.33%
Operating margin (incl. other income)-3523.81%
EBITDA margin-3000.00%
Pre-tax margin-3504.17%
Net profit margin-3504.17%
Net margin, latest quarter-840.00%
ROE-75.81%
ROCE-52.64%
ROA-19.47%
ROE, 3-year average-58.22%
ROCE, 3-year average-49.71%
ROA, 3-year average-26.06%
ROE, 5-year average-22.50%
ROCE, 5-year average-16.01%
ROA, 5-year average-10.35%
ROIC (approx.)-56.06%
Other income / net worth-46.45%
Growth
Sales growth (latest year)-97.34%
Sales CAGR, 3 years-82.91%
Sales CAGR, 5 years-64.13%
Sales growth QoQ-16.67%
Sales growth YoY (latest quarter)150.00%
Per share
EPS (TTM)Rs -1.56
EPS (latest year)Rs -1.61
EPS (latest quarter)Rs -0.08
EPS, 3-year averageRs -2.49
EPS, 5-year averageRs -0.97
Book value per shareRs 1.75
Sales per shareRs 0.04
Cash flow per shareRs -1.12
Free cash flow per shareRs -1.12
Dividend per share, 5-year averageRs 0.07
Dividends
Dividend payout, 5-year average5.64%
Efficiency
Asset turnover0.00x
Fixed asset turnover0.07x
Inventory turnover0.00x
Inventory days115675 days
Debtor days1755 days
Debtors turnover0.21x
Creditor days86286 days
Cash conversion cycle54279 days
Working capital days9855 days
Leverage
Total debtRs 5 Cr
Cash and bankRs 0 Cr
Net debtRs 5 Cr
Debt to equity0.55x
Interest coverage-22.36x
Owners' fund to total sources21.94%
Debt to assets12.00%
Cash flow
Cash from Operating Activity (latest year)Rs -6 Cr
Cash from Financing Activity (latest year)Rs 6 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -6 Cr
FCFE (approx.: FCF + change in debt)Rs -4 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -3 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -4 Cr
EBITDA (TTM)Rs -7 Cr
PBDT (TTM)Rs -8 Cr
Profit before tax (TTM)Rs -8 Cr
Net profit (TTM)Rs -8 Cr
Net profit (latest year)Rs -9 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 3 Cr
Total income (latest year)Rs -4 Cr
Share capitalRs 54 Cr
ReservesRs -45 Cr
Shareholders' fundsRs 9 Cr
Total assetsRs 43 Cr
Net blockRs 3 Cr
ReceivablesRs 1 Cr
InventoryRs 38 Cr
Other liabilitiesRs 28 Cr
Shares outstanding (crore)5.40
Ownership
Promoter holding17.47% (-1.07 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 1.01 is at the 18th percentile (median 7.33).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 516110 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -5.4% | -2.8% | -2.6 pts |
| 1 month | -14.6% | -6.8% | -7.8 pts |
| 3 months | -39.5% | -7.6% | -31.9 pts |
| 3 years | -76.2% | +14.2% | -90.3 pts |
| 5 years | -91.4% | +27.9% | -119.3 pts |
Red flags
F-score 3 of 8| explain | Receivables outrunning sales Receivables grew -50% vs sales -97% in 2026 |
| look | Inventory outrunning sales Inventory grew 0% vs sales -97% in 2026 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr +150.0% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Family Care Hospitals Ltd?
Family Care Hospitals Ltd (516110) has a market capitalisation of Rs 9.61 Cr. at the 2026-10-01 close.
What were Family Care Hospitals Ltd's latest quarterly results?
In the Jun 2026 quarter, Family Care Hospitals Ltd sales was Rs 0 Cr (+150.0% vs Jun 2025) with a net loss of Rs 0 Cr.